Pfizer Acquires Metsera for $4.9B, Increasing into Weight problems and Cardiometabolic Market
What You Ought to Know: – Pfizer Inc. and Metsera, Inc. have entered right into a definitive settlement underneath which Pfizer will purchase Metsera, a clinical-stage biopharmaceutical firm targeted on creating medicines for weight problems and cardiometabolic ailments for $4.9B. – The acquisition is a strategic transfer for Pfizer, permitting IT to enter a major […]









